Status:
TERMINATED
Two Dose Regimens of Nifedipine for the Management of Preterm Labor
Lead Sponsor:
American University of Beirut Medical Center
Conditions:
Labor, Premature
Eligibility:
FEMALE
17-50 years
Phase:
PHASE3
Brief Summary
Preterm birth is one of the most important causes of perinatal morbidity and mortality worldwide. Prevention and treatment of preterm labor is important, not as an end in itself, but as a means of red...
Detailed Description
RESEARCH DESIGN AND METHODS Inclusion criteria: * All pregnant women diagnosed with preterm labor defined as regular contractions associated with cervical change between 24 and 34 weeks of gestation...
Eligibility Criteria
Inclusion
- All pregnant women diagnosed with preterm labor defined as regular contractions associated with cervical change between 24 and 34 weeks of gestation
Exclusion
- Multiple pregnancy
- Preterm rupture of membranes
- Congenital fetal malformations
- IUGR (intra uterine growth restriction)
- Previous tocolysis in this pregnancy
- Chorioamnionitis
- Cervical dilation \> 4 cms
- Maternal medical conditions such as renal insufficiency, hepatic insufficiency, or myasthenia gravis
- Non-reassuring fetal heart rate
- Maternal hypotension, defined as a blood pressure \< 90/50 mmHg
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT00137501
Start Date
May 1 2003
End Date
June 1 2009
Last Update
July 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
American University of Beirut Medical Center
Beirut, Lebanon